For the Inventor, By the Inventor

Enter assignee name

Nanjing Sanhome Pharmaceutical Co., Ltd.

USPTO Granted Patents = 11

CIPO Patents = 4

EPO Patents = 8

Trademarks = 1

Forward Citations = 13

Loading Chart...

Loading Chart...

57 inventors (with patents filed for the assignee):

Yong Wang (10 out of 36 patents)

Liwen Zhao (7 out of 7 patents)

Cang Zhang (5 out of 5 patents)

4. Hongyan Chen (4 out of 4 patents)

5. Di Zhang (3 out of 9 patents)

6. Xiaorong Liu (3 out of 7 patents)

7. Yan Mei Zhang (3 out of 37 patents)

8. Xu Quan (2 out of 2 patents)

9. Chunhuan Jiang (2 out of 2 patents)

10. Guochuang Zheng (2 out of 2 patents)

11. Dandan Huang (2 out of 2 patents)

12. Xian Zhang (2 out of 19 patents)

13. Yiping Gao (2 out of 2 patents)

14. Dezhong Wang (2 out of 2 patents)

15. Yang Nan (2 out of 2 patents)

11 patents: Sort by Forward Citations

1. 12473280 - Substituted tricyclic compound as PRMT5 inhibitor and use thereof (2025-11-18),

2. 11987627 - Anti-CD47 antibody and application thereof (2024-05-21),

3. 11186587 - Compound as ACC inhibitor and use thereof (2021-11-30),

4. 10961222 - Chemical compound of isocitrate dehydrogenase inhibitor, and application thereof (2021-03-30),

5. 10093656 - Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor (2018-10-09),

6. 10077258 - Substituted pyrimidine compounds as phosphatidylinositol 3-kinase delta inhibitor and use thereof (2018-09-18),

7. 9963480 - Nucleoside phosphoramidate compound and use thereof (2018-05-08),

8. 9512108 - 9,9,10,10-Tetrafluoro-9,10-dihydrophenanthrene hepatitis C virus inhibitor and application thereof (2016-12-06),

9. 9255107 - Heteroaryl alkyne compound and use thereof (2016-02-09),

10. 9139574 - Tumor targeted drug combretastatin A4 derivative (2015-09-22),

11. 8530507 - Use of levo-ornidazole in the preparation of anti-anaerobic bacteria infection drugs (2013-09-10),

Nanjing Sanhome Pharmaceutical Co., Ltd. is a leading pharmaceutical company specializing in research, development, and production of innovative medicines. With a focus on improving patient outcomes, Sanhome is dedicated to providing high-quality pharmaceutical products to customers worldwide. The company's portfolio includes a diverse range of therapeutics spanning various therapeutic areas. Sanhome Pharma is committed to advancing healthcare through continuous innovation and excellence in pharmaceutical manufacturing.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

11 Patents

#62 in Jiangsu

#2,258 in China

#50,208 in the World

Nanjing Sanhome Pharmaceutical Co., Ltd.

Forward Citations = 13

57 inventors:

Yong Wang (10 out of 36 patents)

Liwen Zhao (7 out of 7 patents)

Cang Zhang (5 out of 5 patents)

4. Hongyan Chen (4 out of 4 patents)

5. Di Zhang (3 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…